Summary -A new market study, titled “Global China Proton Therapy Market Size, Status and Forecast 2020-2026” has been featured on WiseGuy Reports.
“China Proton Therapy Market Size, Status and Forecast to 2025” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in China. The research includes historic data from 2015 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. The report provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.The report further sheds light on the number of treatment rooms,current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at China proton therapy centers from 2008 to 2016.

ALSO READ https://icrowdnewswire.com/2019/10/17/proton-therapy-market-2019-ch...

However, there are certain factors that are hampering the growth of the market. The complex clinical trials process and high treatment costs are estimated to be the major constraints in the growth of the market. Besides these restraints, growing health awareness and new research and development are estimated to develop myriad growth opportunities for the growth of the market in the near future.
The global China Proton Therapy market is further studied on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America region is estimated to account for a major share in the global China Proton Therapy market owing to the increasing prevalence of liver cancer due to risk factors such as Hepatitis C virus infection and alcoholic liver disease in the region. Additionally, high adoption of innovative technology, established infrastructure for research and development and presence of key pharmaceutical companies are the major factors for growth of liver cancer market in the region. Asia-Pacific is estimated to be the fastest growing market during the forecast period. The growth is observed in the region owing to the growing aged population and increasing health expenditure in the emerging economies such as India and China.
Key players of the global China Proton Therapy market are market are 4SC AG, Alnylam Pharmaceuticals, Inc., ArQule Inc., Aveo Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Co., and so on. In order to stay competitive in the market, these key players adopt strategies such as product launch, merger & acquisitions, FDA approval, geographical expansion and so forth.
Research methodology
The market study of the global China Proton Therapy market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports.
Secondary sources include
• Financial reports of companies involved in the market
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog
The report is intended for healthcare providers, research laboratories and government organization for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
The report covers
• Comprehensive research methodology of the global China Proton Therapy market.
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global China Proton Therapy market.
• Insights about market determinants which are stimulating the global China Proton Therapy market.
• Detailed and extensive market segments with regional distribution of researched revenues.
• Extensive profiles and recent developments of market players.
Companies Mentioned
1. 4SC AG
2. Alnylam Pharmaceuticals, Inc.
3. ArQule, Inc.
4. Aveo Pharmaceuticals, Inc.
5. Bayer AG
6. Becton and Dickinson, Co.
7. Bristol-Myers Squibb, Co.
8. Celsion Corp.
9. Dicerna Pharmaceuticals, Inc.
10. Eli Lilly and Co.
11. Exelixis, Inc.
12. F. Hoffmann-La Roche, Ltd.
13. FibroGen, Inc.
14. General Electric Co.
15. Merck KGaA
16. Novartis International AGThe report also includes assessment of China reimbursement scenario; proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the China proton therapy market.
The report concludes with the profiles of major players in the China proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, China proton therapy centers developed by the companies and recent development of the proton therapy market.
The major companies dominating this market for its products, services and continuous product developments are:
Advanced Oncotherapy, Siemens Healthneers, ProNova Solution, ProTom International, Hitachi, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems
Long–term Growth Projection:
• China represents a significant opportunity in the Global proton therapy market
• China proton therapy market will exhibit a steady CAGR of over 30% by 2025
• The potential China proton therapy market is likely to reach more than USD 10 Billion by 2025
• IBA accounted highest number of proton therapy centers in the forecast period
• Advanced Oncotherapy is emerging with novel technology and significantly impacting the proton therapy market size over the forecast period
The Latest Industry Data Included in this Report:
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis by Company
• China Proton Therapy Market Size & Analysis (2015 – 2025)
• China Proton Therapy Market Opportunity Assessment (2012 – 2025)
• China Number of Treatment Rooms and Forecast (2017 – 2025)
• China Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• China Number of Patients Treated at Proton Therapy Centers (2008 – 2016)
• China Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Major Deals in Proton Therapy Market
• Key Market Drivers and Inhibitors of the China Proton Therapy Market
• Major Companies Analysis
Key Deliverables in the Study
• Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
• Trending factors influencing the market of the China proton therapy market
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides a seven-year forecast which helps to provide a long-term assessment of developments in the China proton therapy market
• Identification and analysis of the macro and micro factors that affect the China proton therapy market
• Identification of factors instrumental in changing the market scenarios, rising prospective opportunities
• A comprehensive list of key market players along with the analysis of their current product portfolios and recent development

17. Nymox Pharmaceutical Corp.
18. Pfizer, Inc.
19. SMC Laboratories, Inc.
20. Thermo Fisher Scientific, Inc.
FOR MORE DETAILS https://www.wiseguyreports.com/reports/3503807-china-proton-therapy...

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
sales@WiseGuy Reports.com
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)